Cochrane Abstracts
Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Gefitinib for Advanced Non-small Cell Lung Cancer: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436068/all/Gefitinib_for_advanced_non_small_cell_lung_cancer:_Cochrane_systematic_review.
Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436068/all/Gefitinib_for_advanced_non_small_cell_lung_cancer:_Cochrane_systematic_review. Accessed December 3, 2024.
Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436068/all/Gefitinib_for_advanced_non_small_cell_lung_cancer:_Cochrane_systematic_review
Gefitinib for Advanced Non-small Cell Lung Cancer: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436068/all/Gefitinib_for_advanced_non_small_cell_lung_cancer:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
ID - 436068
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436068/all/Gefitinib_for_advanced_non_small_cell_lung_cancer:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
